Registry for adults with tic disorders
Adult Tic Disorders Registry
This study is creating a registry for adults with tic disorders to see how tic severity affects their daily lives and to understand any differences between men and women.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 450 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 7 sites (Clermont-Ferrand and 6 other locations) |
| Trial ID | NCT05090943 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry for adults with tic disorders to better understand the relationship between tic severity and the resulting impairment in both women and men. Participants will complete quality of life assessments to provide valuable data for analysis. The study focuses on characterizing differences in tic disorders based on gender, which may lead to improved understanding and management of these conditions.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old diagnosed with tic disorders.
Not a fit: Patients without affiliation to French health social insurance or those with significant congenital disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of tic disorders and lead to better-targeted treatments for patients.
How similar studies have performed: While there may be similar registries, this specific focus on gender differences in tic disorders is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria : 1. Age \>18 years 2. Patients with Tic disorders 3. Given the non-opposition Non Inclusion criteria 1. No affiliation to a French health social insurance 2. Significant congenital disorders that may affect understanding of assessments 3. Patients under guardianship or curatorship
Where this trial is running
Clermont-Ferrand and 6 other locations
- CHU Clermont-Ferrand — Clermont-Ferrand, France (Recruiting)
- CHU Limoges — Limoges, France (Recruiting)
- CHU Marseille — Marseille, France (Recruiting)
- Service de Neurologie, GH Pitié Salpêtrière — Paris, France (Recruiting)
- CHU Poitiers — Poitiers, France (Recruiting)
- CHU Nantes — Saint-Herblain, France (Recruiting)
- CHU Strasbourg — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Emmanuel Flamand-Roze, MD, PhD
- Email: emmanuel.flamand-roze@aphp.fr
- Phone: 1 42 16 06 45
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.